American International Group’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-82,877
| Closed | -$340K | – | 3391 |
|
|
2022
Q1 | $340K | Sell |
82,877
-5,833
| -7% | -$21.2K | ﹤0.01% | 1940 |
|
|
2021
Q4 | $317K | Sell |
88,710
-2,655
| -3% | -$9.29K | ﹤0.01% | 2084 |
|
|
2021
Q3 | $333K | Sell |
91,365
-2,170
| -2% | -$8.77K | ﹤0.01% | 2112 |
|
|
2021
Q2 | $408 | Sell |
93,535
-2,255
| -2% | -$9.19K | ﹤0.01% | 2056 |
|
|
2021
Q1 | $394 | Buy |
95,790
+253
| +0.3% | +$1.1K | ﹤0.01% | 1959 |
|
|
2020
Q4 | $381 | Sell |
95,537
-2,742
| -3% | -$8.87K | ﹤0.01% | 1903 |
|
|
2020
Q3 | $265K | Sell |
98,279
-2,234
| -2% | -$6.18K | ﹤0.01% | 1968 |
|
|
2020
Q2 | $276K | Buy |
100,513
+4,769
| +5% | +$13.3K | ﹤0.01% | 1937 |
|
|
2020
Q1 | $226K | Sell |
95,744
-5,532
| -5% | -$18.8K | ﹤0.01% | 1846 |
|
|
2019
Q4 | $476K | Sell |
101,276
-852
| -0.8% | -$3.49K | ﹤0.01% | 1718 |
|
|
2019
Q3 | $342K | Sell |
102,128
-712
| -0.7% | -$2.34K | ﹤0.01% | 1861 |
|
|
2019
Q2 | $338K | Buy |
102,840
+10,779
| +12% | +$31.2K | ﹤0.01% | 1922 |
|
|
2019
Q1 | $279K | Sell |
92,061
-2,983
| -3% | -$9.67K | ﹤0.01% | 2029 |
|
|
2018
Q4 | $259K | Sell |
95,044
-732
| -0.8% | -$2.41K | ﹤0.01% | 2037 |
|
|
2018
Q3 | $322K | Buy |
95,776
+1,727
| +2% | +$5.33K | ﹤0.01% | 2137 |
|
|
2018
Q2 | $243K | Buy |
94,049
+2,196
| +2% | +$5.46K | ﹤0.01% | 2244 |
|
|
2018
Q1 | $202K | Sell |
91,853
-4,940
| -5% | -$11.1K | ﹤0.01% | 2256 |
|
|
2017
Q4 | $193K | Buy |
96,793
+458
| +0.5% | +$997 | ﹤0.01% | 2337 |
|
|
2017
Q3 | $312K | Buy |
96,335
+7,203
| +8% | +$22.2K | ﹤0.01% | 2038 |
|
|
2017
Q2 | $287K | Buy |
+89,132
| New | +$253K | ﹤0.01% | 2055 |
|
|
2016
Q2 | – | Sell |
-90,637
| Closed | -$79K | – | 4656 |
|
|
2016
Q1 | $79K | Hold |
90,637
| – | – | ﹤0.01% | 3594 |
|
|
2015
Q4 | $110K | Sell |
90,637
-157
| -0.2% | -$218 | ﹤0.01% | 3414 |
|
|
2015
Q3 | $154K | Buy |
90,794
+108
| +0.1% | +$212 | ﹤0.01% | 3063 |
|
|
2015
Q2 | $189K | Buy |
90,686
+17,284
| +24% | +$41.9K | ﹤0.01% | 3060 |
|
|
2015
Q1 | $199K | Hold |
73,402
| – | – | ﹤0.01% | 2951 |
|
|
2014
Q4 | $189K | Sell |
73,402
-2,905
| -4% | -$6.53K | ﹤0.01% | 2995 |
|
|
2014
Q3 | $140K | Sell |
76,307
-56
| -0.1% | -$122 | ﹤0.01% | 3264 |
|
|
2014
Q2 | $204K | Sell |
76,363
-540
| -0.7% | -$1.63K | ﹤0.01% | 2966 |
|
|
2014
Q1 | $269K | Buy |
76,903
+1,841
| +2% | +$8.17K | ﹤0.01% | 2582 |
|
|
2013
Q4 | $336K | Sell |
75,062
-502
| -0.7% | -$2.04K | ﹤0.01% | 2326 |
|
|
2013
Q3 | $307K | Buy |
75,564
+1,899
| +3% | +$8.29K | ﹤0.01% | 2341 |
|
|
2013
Q2 | $306K | Buy |
+73,665
| New | +$285K | ﹤0.01% | 2215 |
|
Other funds holding ATRS
American International Group's ATRS Position: Q2 2022 in Review
American International Group sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 82,877 shares — an estimated $340K sold.
American International Group first reported a position in ATRS in Q2 2013 and held it in 32 quarters. The position peaked at $476K in Q4 2019. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- American International Group reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- American International Group sold 82,877 Antares Pharma, Inc. shares in Q2 2022, an estimated $340K.
- American International Group first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 32 quarters.
- American International Group's Antares Pharma, Inc. position peaked at $476K in Q4 2019.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.